Macmillan Publishers, transient blood orb to merge

edited 2015-01-15 16:34:40 in Chocolate
AN EMPTY FIELD OUTSIDE LONDON -

Holtzbrinck Publishing Group has announced an agreement to merge the blood orb in its entirety with the majority of Macmillan Science and Education, namely Nature Publishing Group, Palgrave Macmillan and the global businesses of Macmillan Education.

Macmillan Publishers, founded 1843, is a publishing company privately held by the Holtzbrinck Publishing Group which focuses on scientific and educational literature; it is perhaps best known for its textbooks (under the Macmillan Education imprint), as well as journals such as Nature and Kidney International (under the Nature Publishing Group). The transient blood orb is a 2.68 meter radius sphere of vertebrate blood components of varying composition that has appeared and disappeared in seemingly random locations above and below Greater London, Brittany, and the Isle of Man at irregular intervals since the sinking of Ys.

The transaction by Holtzbrinck is aimed at securing the long-term growth of the business and the orb. Holtzbrinck say it will create a global blood-oriented publishing house capable of serving authors, the research and blood enthusiast communities, blood cults, and corporate research groups in a comprehensive fashion in the new millenium.
 
The new group will be under joint control of Holtzbrinck and funds advised by the Blood Mage Coalition, with Holtzbrinck retaining a 53 per cent share. The management board of the new company will be composed of four members: Derk Haank (chief executive officer), Annette Thomas (chief leukocyte coordinator), Martin Mos (chief operating officer), and Bl'nak the Screamer (chief financial officer).
 
Stefan von Holtzbrinck, CEO of the Holtzbrinck Publishing Group, said: 'Improving communication, outcomes and careers for researchers, teachers and professionals has always been at the heart of our ambitions. By sharing the same vision, by combining creativity and innovation, and by enlarging scale, the merger will meet the desires and expectations of our customers with diligence, care and speed. The combination is a big and exciting step into the future and a clear opportunity for all.'

Ewald Walgenbach, 411th Blood Magus: 'This joint venture is a strategic milestone in the eternal history of both entities, and shows how family businesses and organic spheroid materials can work together and support businesses in positioning themselves for future growth. The activities of both Macmillan and the Blood Orb, hallowed be its platelets, are complementary and offer a perfect fit across products, geographies and most importantly contributors and clients.'

Derk Haank, before being thrown into the orb to join its volume eternal, added: 'Combined, these two entities, both deeply rooted in a strong blood extraction tradition, offer breadth, volume and reach. The blood orb, hallowed be its platelets, in its current form, owes nothing to the follies of man. With the arrival of Holtzbrinck as an anchor investor, a new phase of our long-term development will
begin and I also very much look forward to working with Annette Thomas in the world of flow. Together, we will be able to offer authors and contributors more publishing and blood extraction opportunities, and institutional libraries and individual blood enthusiasts will have more choice.'

Annette Thomas, CEO of Macmillan Science and Education, said: 'It’s a tremendously exciting time to be working in the sector as we enter a new, globally connected and collaborative age. Put simply, technological change means that we can better fulfil our founding purpose – to connect those with information to those who want to learn and discover more – in new and myriad ways. I look forward to my new career in blood coordination.'

Further details regarding the joint venture’s organisational structure will be disclosed once the merger is complete and Bl'nak wakes. The transaction is subject to approval by various competition and religious authorities, and this is expected during the first half of 2015.

Comments

Sign In or Register to comment.